- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07878845
Kinesiology Taping Versus Self-Mobilization for Neck Pain Related to Prolonged Electronic Device Use
Effects of Kinesiology Taping Versus Self-Sustained Natural Apophyseal Glide Mobilization on Pain, Neck Disability, Cervical Proprioception, Respiratory Muscle Strength, and Upper Trapezius Muscle Activity in Individuals With Neck Pain Related to Prolonged Electronic Device Use: A Randomized Controlled Trial
The goal of this clinical trial is to learn whether kinesiology taping or self-mobilization better reduces neck pain in adults who use electronic devices for long periods each day. The main questions it aims to answer are:
- Does kinesiology taping or self-mobilization lead to greater reduction in neck pain after 4 weeks?
- Do the two treatments differ in their effects on neck-related disability, neck position sense, breathing muscle strength, and upper trapezius muscle activity?
Researchers will compare kinesiology taping with self-sustained natural apophyseal glide (self-SNAG) mobilization to see which approach is more effective.
Participants will:
- Be randomly assigned to one of the two treatment groups
- Receive kinesiology tape applied to the back of the neck every 4 days for 4 weeks, or learn and perform a towel-assisted neck self-mobilization exercise for 4 weeks
- Receive education on posture and self-management
- Complete assessments of pain, neck disability, neck position sense, breathing muscle strength, and neck-shoulder muscle activity at the start of the study, after 4 weeks, and 1 month later
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Prolonged use of electronic devices is associated with sustained cervical flexion and altered activation of the cervicoscapular musculature, particularly the upper trapezius. Kinesiology taping and Mulligan self-mobilization are commonly used conservative approaches; however, their comparative effects on pain, cervical proprioception, respiratory muscle strength, and muscle activity in this population remain unclear.
In this single-blind, two-arm, parallel-group randomized controlled trial, adults with neck pain (VAS > 3/10) and a history of electronic device use of at least 4 hours per day during the preceding year will be randomized to kinesiology taping (8 applications over 4 weeks) or self-SNAG mobilization performed with mirror-based visual feedback. Both groups will receive standardized education on posture and self-management.
Bilateral upper trapezius surface electromyography will be recorded during isometric shoulder elevation using a wireless sEMG system, with electrode placement according to SENIAM guidelines, and normalized to maximum voluntary isometric contraction. A bilateral upper trapezius EMG asymmetry index will be derived from the normalized right- and left-side values.
Primary and secondary outcomes will be analyzed using linear mixed-effects models with random intercepts for participants. As a pre-specified secondary analysis, the association between baseline bilateral upper trapezius EMG asymmetry and change in pain intensity will be examined, including its interaction with treatment group.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Emrah Zirek Assistant Professor, Ph. D.
- Phone Number: +905446457700
- Email: ezirek@bingol.edu.tr
Study Locations
-
-
Bingöl
-
Bingoel, Bingöl, Turkey (Türkiye), 12000
- Recruiting
- Bingol University, Faculty of Physical Therapy and Rehabilitation
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age 18 years or older
- Neck pain with an intensity greater than 3 on a 10-point Visual Analog Scale
- Use of electronic devices for at least 4 hours per day during the preceding year
- Willingness to participate and provision of written informed consent
Exclusion Criteria:
- Cervical or shoulder surgery within the past 6 months
- Previously diagnosed cervical pathology, including whiplash-associated disorder, cervical spondylolisthesis, disc herniation, or rheumatoid arthritis
- Current use of analgesics, opioids, or corticosteroids
- Skin allergy, open wounds, or skin lesions in the cervical region that preclude kinesiology tape application
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Kinesiology Taping
Participants receive kinesiology tape (5 cm wide, 0.5 mm thick, water-resistant) applied to the posterior cervical region in a seated neutral position. A Y-strip is applied over the cervical extensors from T1-T2 to C1-C2 with approximately 25% tension, and a second strip is applied perpendicularly across C3-C6. The tape is reapplied every 4 days by a trained physiotherapist for a total of 8 applications over 4 weeks. Participants also receive standardized education on posture and self-management. |
Elastic therapeutic tape applied to the posterior cervical region (Y-strip over the cervical extensors with approximately 25% tension and a perpendicular strip across C3-C6), reapplied every 4 days for 8 applications over 4 weeks. |
|
Active Comparator: Self-SNAG Mobilization
Participants are trained by an experienced physiotherapist to perform towel-assisted self-administered sustained natural apophyseal glide (self-SNAG) mobilization at the C5 level, with mirror-based visual feedback. The end-range rotation position is sustained for 3 seconds, with 10 repetitions per session within a pain-free range, [frequency, e.g., once daily] for 4 weeks. Participants also receive standardized education on posture and self-management. |
Towel-assisted self-administered sustained natural apophyseal glide at C5 with mirror-based visual feedback, 10 repetitions per session with 3-second end-range holds, performed over 4 weeks. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Neck Pain Intensity (Visual Analog Scale)
Time Frame: Baseline and week 4 (end of intervention)
|
Neck pain intensity is assessed using a 10-point Visual Analog Scale (0 = no pain, 10 = worst imaginable pain). Higher scores indicate greater pain. |
Baseline and week 4 (end of intervention)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Neck-Related Disability (Neck Disability Index)
Time Frame: Baseline, week 4, and week 8
|
Self-reported neck-related disability is assessed using the 10-item Neck Disability Index (total score 0-50). Higher scores indicate greater disability. |
Baseline, week 4, and week 8
|
|
Change in Cervical Joint Position Sense Error
Time Frame: Baseline, week 4, and week 8
|
Cervical joint position sense error is measured in centimeters using a head-mounted laser pointer and a target placed 90 cm from the seated participant, following active cervical flexion, extension, and left and right rotation. The mean deviation across five repetitions per direction is recorded. Higher values indicate poorer proprioceptive accuracy. |
Baseline, week 4, and week 8
|
|
Change in Upper Trapezius Muscle Activity (Surface Electromyography)
Time Frame: Baseline, week 4, and week 8
|
Bilateral upper trapezius activity is recorded with wireless surface electromyography during isometric shoulder elevation (three 7-second contractions) and expressed as root-mean-square amplitude normalized to maximum voluntary isometric contraction (%MVIC). |
Baseline, week 4, and week 8
|
|
Bilateral Upper Trapezius EMG Asymmetry Index
Time Frame: Baseline, week 4, and week 8
|
EMG asymmetry is calculated from normalized right- and left-side upper trapezius activity as |Right - Left| / [(Right + Left) / 2] x 100. A value of 0% indicates perfect symmetry; higher values indicate greater bilateral imbalance. Baseline asymmetry will be examined as a predictor of change in pain intensity. |
Baseline, week 4, and week 8
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- BINGOL-7-5
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Individual participant data will not be shared publicly. De-identified data may be made available from the principal investigator upon reasonable request.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.